C

CTI Biopharma Corp
F:CEPS

Watchlist Manager
CTI Biopharma Corp
F:CEPS
Watchlist
Price: 28 EUR Market Closed
Market Cap: 3.7B EUR

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of CEPS.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CEPS Intrinsic Value
Not Available
C
Base Case Scenario

Fundamental Analysis

CTI Biopharma Corp
F:CEPS
US
Biotechnology
Market Cap
3.7B EUR
IPO
Mar 21, 1997
US
Biotechnology
Market Cap
3.7B EUR
IPO
Mar 21, 1997
Price
€false
EPS
$false
Company Overview
Loading...
Business Segments
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about CTI Biopharma Corp
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
CTI Biopharma Corp

Current Assets 86.5m
Cash & Short-Term Investments 59m
Receivables 23m
Other Current Assets 4.5m
Non-Current Assets 25.8m
PP&E 1.9m
Intangibles 22.7m
Other Non-Current Assets 1.2m
Efficiency

Free Cash Flow Analysis
CTI Biopharma Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
CTI Biopharma Corp

Revenue
75.8m USD
Cost of Revenue
-4.5m USD
Gross Profit
71.3m USD
Operating Expenses
-125.2m USD
Operating Income
-53.9m USD
Other Expenses
-15.3m USD
Net Income
-69.2m USD
Fundamental Scores

CEPS Profitability Score
Profitability Due Diligence

CTI Biopharma Corp's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Exceptional 3-Years Revenue Growth
Exceptional ROE
Positive Gross Profit
48/100
Profitability
Score

CTI Biopharma Corp's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

CEPS Solvency Score
Solvency Due Diligence

CTI Biopharma Corp's solvency score is 35/100. The higher the solvency score, the more solvent the company is.

Low D/E
Positive Net Debt
Short-Term Solvency
Long-Term Solvency
35/100
Solvency
Score

CTI Biopharma Corp's solvency score is 35/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CEPS Price Targets Summary
CTI Biopharma Corp

There are no price targets for CEPS.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for CEPS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest